Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Adjuvant anlotinib plus TACE in hepatocellular carcinoma with postoperative high-risk recurrence: a single-arm, multi-center, phase II study.
Zheng Wang, Lei Zhang, Xin Zheng, Dong Zhang, Xue Yang, Kedong Xu, Jie Tao, Xiaojing Song, Jian Ma, Zheng Wu
Published: 202610.1007/s12094-025-04160-0
Abstract
PURPOSE: This study assessed the efficacy and safety of anlotinib plus transcatheter arterial chemoembolization (TACE) as adjuvant therapy in hepatocellular carcinoma (HCC) at high-risk recurrence after resection. METHODS: This multi-center, single-a…
Preview only. Read the full abstract at the source